A dose of private equity is apparently just what the doctor ordered. On Tuesday, UK-based PE firm Vitruvian Partners made a $ 637 million strategic investment in DeepIntent, a health care-focused demand-side platform that specializes in helping pharma brands reach patients and providers using programmatic advertising. Although Vitruvian’s portfolio includes a bunch of software, consumer tech […]
The post Health Care DSP DeepIntent Sells $ 637 Million Majority Stake To PE Firm Vitruvian Partners appeared first on AdExchanger.
More Stories
DoorDash and Live Nation ANZ announce three year partnership
Nielsen survey show magazine audiences on the rise
Google Dodged a Breakup, but Experts Say Alternatives Are Misdirected